TECNOTREE
23.2.2024 10:30:26 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, announced the simultaneous rollout of their digital BSS solutions for telecom service providers spanning across the Middle East and Africa. The milestone included 14 Go-lives globally for some of the largest Telecom, Healthcare and Realty groups across North America, the Middle East, Africa and Latam, delivering large-scale Digital BSS transformation for customers on public and private cloud through the Tecnotree Digital Suite (Tecnotree Edge).
The digital stack deployed under various transformation projects include Out of the Box capabilities of Tecnotree’s Digital Suite: Debt Management System, BSS-Switch with Convergent Online Charging System (COCS), Service Provisioning System (SPS), New Bill Layout Designer (BLD), Customer Lifecycle Manager (CLM), and more. By leveraging Tecnotree’s AI-powered, intelligent digital solutions, service providers will be able to align their capabilities with the evolving business needs. The comprehensive solutions will help deliver superior digital customer experience and transformation, introducing the next generation of services for their customers.
Tecnotree’s digital suite empowers robust capabilities for customer tracking across various channels, providing an enhanced 360-degree view of all interactions. This highly automated, full Digital stack, coupled with TMF Open API and ODA Compliant Architecture, facilitates faster service rollouts, ushering in new levels of agility and speed in an increasingly competitive and fast-paced market.
Padma Ravichander, CEO of Tecnotree Corporation said, “We take immense pride in the successful series of go-lives as they represent our unwavering focus on delivering large-scale digital transformation for our customers across various regions. We are enabling the next wave of digital transformation, aligning with the rapidly growing markets. The multiple and simultaneous go-lives speak to the predictability and stability of the Tecnotree Digital Stack in terms of its reliability, dynamic version upgrades, and autopilot capabilities.
With Tecnotree's comprehensive full-stack solution, operators can deliver new and innovative value-added services, unlocking new opportunities and revenue streams. The digital transformations will propel operational efficiencies for operators, enabling them to deliver personalized customer engagement while ensuring seamless and rapid upgrades of features. The offerings will be combined with deep insights in terms of customer experiences, with our embedded, augmented, and cognitive AI use cases on the stack.”
Ramaseshan Subramanian, Chief Delivery Officer, SVP Tecnotree said, “Overseeing the parallel launches of our cutting-edge digital BSS solutions for major telecom providers across the Middle East and Africa has been a testament to our commitment to provide the best-in-class delivery in an agile customer-success driven environment. Our accomplishment of orchestrating 14 successful go-lives for major operator groups worldwide represents a milestone in delivering extensive Digital BSS transformations through the Tecnotree Digital Suite, and further strengthens our commitment to enhance customer-centricity and operational efficiency.”
Shahbaz Ahmad Rashid, Head MEA & Europe, SVP Sales Tecnotree Corporation said, “We’re thrilled about the various successful go-lives which will accelerate digital transformation and deliver world-class experiences to our customers. With the intelligent, digital solutions from Tecnotree, these Opcos will be in a better position to meet the evolving needs of customers, while also accelerating sales, streamlining operations, and driving new monetization opportunities.”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223931032/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom